NASDAQ:VRCA | Free Cash Flow | Verrica Pharmaceuticals Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$9.16M
2025-12-31-$4.59M$0.00-$4.59M
2025-03-31-$12.68M
2024-12-31-$16.06M$0.00-$16.06M
2024-03-31-$19.95M$0.00-$19.95M
2023-12-31-$14.51M$227,000.00-$14.73M
2023-03-31-$4.59M$11,000.00-$4.6M
2022-12-31-$4.95M$66,000.00-$5.02M
2022-03-31-$8.34M$5,000.00-$8.35M
2021-12-31-$8.7M$237,000.00-$8.94M
2021-03-31-$10.79M$311,000.00-$11.1M
2020-12-31-$6.1M$544,000.00-$6.64M
2020-03-31-$7.91M$699,000.00-$8.61M
2019-12-31-$8.21M$3,000.00-$8.22M
2019-03-31-$6.92M
2018-12-31-$6.9M$650,000.00-$7.55M
2018-03-31-$2.15M$17,000.00-$2.17M
2017-12-31-$1.85M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$17.63M$0.00-$17.63M
2024-12-31-$60.93M$27,000.00-$60.95M
2023-12-31-$38.58M$362,000.00-$38.94M
2022-12-31-$18.65M$302,000.00-$18.95M
2021-12-31-$27.58M$883,000.00-$28.47M
2020-12-31-$30.21M$1.47M-$31.68M
2019-12-31-$27.41M$682,000.00-$28.09M
2018-12-31-$17.87M$774,000.00-$18.65M
2017-12-31-$4.58M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.